Personal Vaporizer vs Cigalike
VAPECIG 2
Head-To-Head Comparision of Personal Vaporizers Versus Cigalike: Prospective 6-Month Randomized Control Design Study
1 other identifier
interventional
200
1 country
1
Brief Summary
This is a pilot study to compare efficiency and tolerability of a personal vaporizers (PV) new generation electronic cigarette loaded with nicotine e-liquid with cigalike new generation electronic cigarette loaded with nicotine and usual smoking habits, in a group of well characterized regular smokers unwilling to quit.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2014
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 9, 2014
CompletedStudy Start
First participant enrolled
October 1, 2014
CompletedFirst Posted
Study publicly available on registry
March 25, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2015
CompletedDecember 2, 2015
December 1, 2015
1.2 years
June 9, 2014
December 1, 2015
Conditions
Outcome Measures
Primary Outcomes (1)
Smoking Reduction
50% reduction of cigarette smoked compared to baseline
24 week
Secondary Outcomes (1)
Smoking Cessation
24 week
Study Arms (3)
Personal Vaporizer
ACTIVE COMPARATORPersonal Vaporizer loaded with nicotine
Cigalike
ACTIVE COMPARATORCigalike loaded with nicotine
Usual smoking
NO INTERVENTIONInterventions
Personal Vaporizer 16 mg nicotine or 9 mg nicotine
Eligibility Criteria
You may qualify if:
- in good general health
- committed to follow the trial procedures
You may not qualify if:
- recent vaping history (stopped vaping less than 3 months ago)
- use of any other form of non combustible nicotine containing products (chewable tobacco or nicotine replacement therapy) symptomatic cardiovascular disease
- clinical history of asthma and chronic obstructive pulmonary disease (COPD)
- regular psychotropic medication use
- current or past history of alcohol abuse
- use of smokeless tobacco or nicotine replacement therapy, and pregnancy or breastfeeding.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centro per la Prevenzione e Cura del Tabagismo University of Catania
Catania, Catania, 95100, Italy
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
June 9, 2014
First Posted
March 25, 2015
Study Start
October 1, 2014
Primary Completion
December 1, 2015
Study Completion
December 1, 2015
Last Updated
December 2, 2015
Record last verified: 2015-12